These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15731778)

  • 61. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
    Lai S; El-Naggar AK
    Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combined analysis of p53 and RB pathways in epithelial ovarian cancer.
    Hashiguchi Y; Tsuda H; Yamamoto K; Inoue T; Ishiko O; Ogita S
    Hum Pathol; 2001 Sep; 32(9):988-96. PubMed ID: 11567230
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
    Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
    Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
    Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
    Muirhead DM; Hoffman HT; Robinson RA
    J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
    J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers.
    Hommura F; Dosaka-Akita H; Kinoshita I; Mishina T; Hiroumi H; Ogura S; Katoh H; Kawakami Y
    Br J Cancer; 1999 Oct; 81(4):696-701. PubMed ID: 10574258
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
    Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
    [TBL] [Abstract][Full Text] [Related]  

  • 70. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
    Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
    Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
    Choi YL; Park SH; Jang JJ; Park CK
    J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm.
    Tsuda H; Hashiguchi Y; Nishimura S; Kawamura N; Inoue T; Yamamoto K
    Gynecol Oncol; 2003 Dec; 91(3):476-85. PubMed ID: 14675665
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
    Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Further evidence that altered p16/CDKN2 gene expression is associated with lymph node metastasis in squamous cell carcinoma of the esophagus.
    Takeuchi H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
    Oncol Rep; 2001; 8(3):627-32. PubMed ID: 11295092
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression.
    Peiró G; Diebold J; Löhrs U
    Am J Clin Pathol; 2002 Dec; 118(6):922-9. PubMed ID: 12472286
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
    Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
    Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
    Creager AJ; Cohen JA; Geradts J
    Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.
    Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Warnakulasuriya S; Forteza J; Fraga M
    J Oral Pathol Med; 2012 Aug; 41(7):559-67. PubMed ID: 22417132
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy.
    Brantley MA; Worley L; Harbour JW
    Am J Ophthalmol; 2002 Feb; 133(2):242-8. PubMed ID: 11812429
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.
    Schrage YM; Lam S; Jochemsen AG; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
    J Cell Mol Med; 2009 Sep; 13(9A):2843-52. PubMed ID: 18624751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.